153 related articles for article (PubMed ID: 30049256)
21. Mixed Chlamydia trachomatis Peptide Antigens Provide a Specific and Sensitive Single-Well Colorimetric Enzyme-Linked Immunosorbent Assay for Detection of Human Anti
Rahman KS; Darville T; Wiesenfeld HC; Hillier SL; Kaltenboeck B
mSphere; 2018 Nov; 3(6):. PubMed ID: 30404936
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of a PGP3 ELISA for surveillance of the burden of Chlamydia infection in women from Australia and Samoa.
Mazraani R; Timms P; Hill PC; Suaalii-Sauni T; Niupulusu T; Temese SVA; Iosefa-Siitia L; Auvaa L; Tapelu SA; Motu MF; Righarts A; Walsh MS; Rombauts L; Allan JA; Horner P; Huston WM
Pathog Dis; 2019 Apr; 77(3):. PubMed ID: 31201421
[TBL] [Abstract][Full Text] [Related]
23. Discovery of Human-Specific Immunodominant
Rahman KS; Darville T; Russell AN; O'Connell CM; Wiesenfeld HC; Hillier SL; Chowdhury EU; Juan YC; Kaltenboeck B
mSphere; 2018 Aug; 3(4):. PubMed ID: 30068558
[No Abstract] [Full Text] [Related]
24. Detection of Chlamydia trachomatis antigen by enzyme immunoassay in patients with pelvic inflammatory disease.
Lal H; Rathee S; Sharma D; Chaudhary S
Indian J Med Res; 1992 Mar; 95():77-8. PubMed ID: 1601474
[TBL] [Abstract][Full Text] [Related]
25. Importance of species-specific antigens in the serodiagnosis of Chlamydia trachomatis reactive arthritis.
Bas S; Genevay S; Schenkel MC; Vischer TL
Rheumatology (Oxford); 2002 Sep; 41(9):1017-20. PubMed ID: 12209035
[TBL] [Abstract][Full Text] [Related]
26. [The importance of using a test to detect Chlamydia trachomatis infection in patients undergoing counseling and testing for sexually transmitted diseases at a public health center].
Hatori T; Nakamura T; Tsukui S
Nihon Koshu Eisei Zasshi; 2013; 60(11):691-6. PubMed ID: 24418917
[TBL] [Abstract][Full Text] [Related]
27. Mucosal and systemic immune responses to plasmid protein pgp3 in patients with genital and ocular Chlamydia trachomatis infection.
Ghaem-Maghami S; Ratti G; Ghaem-Maghami M; Comanducci M; Hay PE; Bailey RL; Mabey DC; Whittle HC; Ward ME; Lewis DJ
Clin Exp Immunol; 2003 Jun; 132(3):436-42. PubMed ID: 12780690
[TBL] [Abstract][Full Text] [Related]
28. Latent class modeling to compare testing platforms for detection of antibodies against the Chlamydia trachomatis antigen Pgp3.
Wiegand RE; Cooley G; Goodhew B; Banniettis N; Kohlhoff S; Gwyn S; Martin DL
Sci Rep; 2018 Mar; 8(1):4232. PubMed ID: 29523810
[TBL] [Abstract][Full Text] [Related]
29. Chlamydia trachomatis Pgp3 Antibody Population Seroprevalence before and during an Era of Widespread Opportunistic Chlamydia Screening in England (1994-2012).
Woodhall SC; Wills GS; Horner PJ; Craig R; Mindell JS; Murphy G; McClure MO; Soldan K; Nardone A; Johnson AM
PLoS One; 2017; 12(1):e0152810. PubMed ID: 28129328
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of a field test for antibodies against Chlamydia trachomatis during trachoma surveillance in Nepal.
Sun MJ; Zambrano AI; Dize L; Munoz B; Gwyn S; Mishra S; Martin DL; Sharma S; West SK
Diagn Microbiol Infect Dis; 2017 May; 88(1):3-6. PubMed ID: 28214223
[TBL] [Abstract][Full Text] [Related]
31. Humoral immune response to plasmid protein pgp3 in patients with Chlamydia trachomatis infection.
Comanducci M; Manetti R; Bini L; Santucci A; Pallini V; Cevenini R; Sueur JM; Orfila J; Ratti G
Infect Immun; 1994 Dec; 62(12):5491-7. PubMed ID: 7960130
[TBL] [Abstract][Full Text] [Related]
32. The Performance of Immunoassays to Measure Antibodies to the Chlamydia trachomatis Antigen Pgp3 in Different Epidemiological Settings for Trachoma.
Gwyn S; Nute AW; Sata E; Tadesse Z; Chernet A; Haile M; Zeru T; Bethea D; Laurent C; Callahan EK; Nash SD; Martin DL
Am J Trop Med Hyg; 2021 Aug; 105(5):1362-1367. PubMed ID: 34398819
[TBL] [Abstract][Full Text] [Related]
33. Serological profiling with Chlamycheck, a commercial multiplex recombinant antigen Western blot assay of chlamydial infections.
Radouani F; Maile J; Betsou F
Can J Microbiol; 2007 Dec; 53(12):1360-8. PubMed ID: 18059568
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of two techniques for serological diagnosis of chlamydial infections: MIF and immunoblotting].
Saadouni A; Tbai N; Takourt B
Ann Biol Clin (Paris); 2013; 71(6):663-6. PubMed ID: 24342787
[TBL] [Abstract][Full Text] [Related]
35. Seroprevalence of Chalmydia trachomatis infection amongst patients with pelvic inflammatory diseases and infertility.
Vidhani S; Mehta S; Bhalla P; Bhalla R; Sharma VK; Batra S
J Commun Dis; 2005 Sep; 37(3):233-8. PubMed ID: 17080708
[TBL] [Abstract][Full Text] [Related]
36. Optimization of candidate proteins for serological screening of Chlamydia trachomatis infection.
Gao XB; Xiao M; Wang J; Liu YJ; Liu QZ; Qi ML
Genet Mol Res; 2015 Oct; 14(4):12240-6. PubMed ID: 26505372
[TBL] [Abstract][Full Text] [Related]
37. Comparison of serological assays for detection of Chlamydia trachomatis antibodies in different groups of obstetrical and gynecological patients.
Bax CJ; Mutsaers JA; Jansen CL; Trimbos JB; Dörr PJ; Oostvogel PM
Clin Diagn Lab Immunol; 2003 Jan; 10(1):174-6. PubMed ID: 12522057
[TBL] [Abstract][Full Text] [Related]
38. Identification and evaluation of a combination of chlamydial antigens to support the diagnosis of severe and invasive Chlamydia trachomatis infections.
Forsbach-Birk V; Simnacher U; Pfrepper KI; Soutschek E; Kiselev AO; Lampe MF; Meyer T; Straube E; Essig A
Clin Microbiol Infect; 2010 Aug; 16(8):1237-44. PubMed ID: 19723133
[TBL] [Abstract][Full Text] [Related]
39. Screening for chlamydial infections in women with pelvic inflammatory diseases.
Chowdhary A; Malhotra VL; Deb M; Rai U
J Commun Dis; 1998 Sep; 30(3):163-6. PubMed ID: 10093422
[TBL] [Abstract][Full Text] [Related]
40. [Serodiagnosis of Chlamydia trachomatis and Chlamydia pneumoniae. Evaluation comparing 2 methods: microimmunofluorescence and ELISA. A study of 216 Congolese sera].
Biendo M; Orfila J
Bull Soc Pathol Exot; 1994; 87(2):81-4. PubMed ID: 8061532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
